Literature DB >> 24802113

Type AB thymoma is not a mixed tumor of type A and type B thymomas, but a distinct type of thymoma.

Yukari Miki1, Kana Hamada, Tadashi Yoshino, Katsuya Miyatani, Kiyoshi Takahashi.   

Abstract

Type AB thymoma is generally regarded to be a mixture of type A and type B thymomas, but has not been studied extensively. In this study, we precisely investigated the characteristics of type AB thymoma immunohistochemically and compared it with other types of thymoma, including type A, metaplastic, and type B1 thymoma. In type A thymoma, the tumor cells were composed solely of pan-cytokeratin (CK-AE1/AE3)(+) claudin-1(+) vimentin(-) epithelial membrane antigen (EMA)(-) short spindle cells. Metaplastic thymoma exhibited biphasic architecture of epithelial islands of short spindle cells, which were phenotypically almost identical to the tumor cells in type A thymoma, and anastomosing bundles of CK-AE1/AE3(-) claudin-1(-) vimentin(+) EMA(+) fibroblast-like long spindle-shaped epithelial cells. Interestingly, we found that there were two distinctive subtypes of cell in type AB thymoma: the conventional subtype and the metaplastic subtype. The conventional subtype is characterized by type A-like components resembling type A thymoma. The metaplastic subtype is characterized by type A-like components extensively resembling the anastomosing bundles of fibroblast-like long spindle epithelial cells. Interestingly, the metaplastic subtype was a major subtype (14/19 cases), while the conventional subtype was a minor one (5/19 cases). In contrast to the rarity of metaplastic thymoma, the metaplastic subtype of type AB thymoma appears to be a major subtype of type AB thymoma.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24802113     DOI: 10.1007/s00428-014-1587-5

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  36 in total

1.  Thymoma: a clinicopathologic study.

Authors:  P E BERNATZ; E G HARRISON; O T CLAGETT
Journal:  J Thorac Cardiovasc Surg       Date:  1961-10       Impact factor: 5.209

Review 2.  Claudins: multifunctional players in epithelial tight junctions and their role in cancer.

Authors:  S S Oliveira; J A Morgado-Díaz
Journal:  Cell Mol Life Sci       Date:  2007-01       Impact factor: 9.261

3.  Mesenchymal cells are required for functional development of thymic epithelial cells.

Authors:  Manami Itoi; Noriyuki Tsukamoto; Hisahiro Yoshida; Takashi Amagai
Journal:  Int Immunol       Date:  2007-07-11       Impact factor: 4.823

Review 4.  Loss of tight junction barrier function and its role in cancer metastasis.

Authors:  Tracey A Martin; Wen G Jiang
Journal:  Biochim Biophys Acta       Date:  2008-11-14

5.  The evaluation of immunohistochemical markers and thymic cortical microenvironmental cells in distinguishing thymic carcinoma from type b3 thymoma or lung squamous cell carcinoma.

Authors:  Atsushi Hayashi; Takumi Fumon; Yukari Miki; Hiaki Sato; Tadashi Yoshino; Kiyoshi Takahashi
Journal:  J Clin Exp Hematop       Date:  2013

Review 6.  Thymoma, atypical thymoma, and thymic carcinoma. A novel conceptual approach to the classification of thymic epithelial neoplasms.

Authors:  S Suster; C A Moran
Journal:  Am J Clin Pathol       Date:  1999-06       Impact factor: 2.493

7.  Cellular networks of human thymic medullary stromas coordinated by p53-related transcription factors.

Authors:  Shingo Ichimiya; Takashi Kojima
Journal:  J Histochem Cytochem       Date:  2006-08-21       Impact factor: 2.479

8.  New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China.

Authors:  Gang Chen; Alexander Marx; Wen-Hu Chen; Jiang Yong; Bernhard Puppe; Philipp Stroebel; Hans Konrad Mueller-Hermelink
Journal:  Cancer       Date:  2002-07-15       Impact factor: 6.860

9.  Metaplastic thymoma: report of an unusual thymic epithelial neoplasm arising in the wall of a thymic cyst.

Authors:  Mihan Poorabdollah; Ehsan Mehdizadeh; Foruzan Mohammadi; Shahram Sabeti
Journal:  Int J Surg Pathol       Date:  2008-04-07       Impact factor: 1.271

10.  Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study.

Authors:  Anna-Mária Tokés; Janina Kulka; Sándor Paku; Agnes Szik; Csilla Páska; Pál Kaposi Novák; László Szilák; András Kiss; Krisztina Bögi; Zsuzsa Schaff
Journal:  Breast Cancer Res       Date:  2005-01-31       Impact factor: 6.466

View more
  4 in total

1.  Upregulated expression of NKG2D and its ligands give potential therapeutic targets for patients with thymoma.

Authors:  X Y Xuan; J F Zhang; G M Hu; Q R Li; P P Liu; Y Du
Journal:  Cancer Gene Ther       Date:  2015-06-26       Impact factor: 5.987

2.  Metaplastic thymoma with myasthenia gravis presumably caused by an accumulation of intratumoral immature T cells: a case report.

Authors:  Shogo Tajima; Masahiro Yanagiya; Masaaki Sato; Jun Nakajima; Masashi Fukayama
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

3.  High CTLA-4 expression correlates with poor prognosis in thymoma patients.

Authors:  Giorgio Santoni; Consuelo Amantini; Maria Beatrice Morelli; Daniele Tomassoni; Matteo Santoni; Oliviero Marinelli; Massimo Nabissi; Claudio Cardinali; Vittorio Paolucci; Mariangela Torniai; Silvia Rinaldi; Francesca Morgese; Giovanni Bernardini; Rossana Berardi
Journal:  Oncotarget       Date:  2018-03-30

4.  YAP1-MAML2 Fusion as a Diagnostic Biomarker for Metaplastic Thymoma.

Authors:  Jikai Zhao; Ruiying Zhao; Chan Xiang; Jinchen Shao; Lianying Guo; Yuchen Han
Journal:  Front Oncol       Date:  2021-07-20       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.